Addiction News and Research

RSS

New PET imaging approach may enable early CTE diagnosis

A first-in-class PET imaging approach can accurately detect a biomarker for chronic traumatic encephalopathy (CTE), a devastating neurodegenerative disease associated with repeated head impact.

31 May 2026

WHO urges global governments to protect youth from nicotine addiction

Worldwide, at least 40 million children aged 13–15 use tobacco products, and young people's use of e-cigarettes and nicotine pouches continues to rise. In advance of World No Tobacco Day – 31 May – the World Health Organization (WHO) urges governments around the world to protect a new generation from becoming addicted to tobacco and nicotine products.

30 May 2026

Herbal cigarettes are not safer than regular tobacco alternatives

Herbal cigarettes, widely sold in India and abroad as natural, tobacco-free, and even therapeutic alternatives to conventional cigarettes, are not safer than regular tobacco cigarettes.

29 May 2026

Preschool gaming habits may shape problematic gaming symptoms later in life

The study identifies preschool gaming as a strong predictor of adult internet gaming disorder, highlighting the role of early exposure in addiction risk.

29 May 2026

Tobacco price cap could raise billions and improve public health

The UK could raise up to £4.9 billion over five years and significantly improve public health by capping tobacco prices and increasing taxes.

27 May 2026

Psilocybin may provide long-lasting relief from chronic nerve pain

A single dose of psilocybin - the active compound in magic mushrooms - reduces nerve pain for up to a month and makes a widely used painkiller work more effectively, University of Reading research has found.

22 May 2026

Innovative platform bridges the gap between OUD treatment and HIV prevention

People with opioid use disorder (OUD) are at increased risk of contracting human immunodeficiency virus (HIV). While there are effective interventions that can substantially reduce HIV incidence and opioid overdose, like pre-exposure prophylaxis (PrEP) and medications for opioid use disorder (MOUD), many patients still face barriers to accessing and staying engaged in care.

22 May 2026

GLP-1 drugs may help curb addiction by targeting reward pathways

GLP-1 receptor agonists, already used for Type 2 diabetes and obesity, show promise in reducing alcohol and drug-seeking behaviors through central reward and dopamine-related pathways. Most evidence remains preclinical, with limited early human data, so larger clinical trials are needed before these drugs can be recommended for addiction treatment.

21 May 2026

Real-time memory tests identify alcohol-induced blackouts as they happen

It's not surprising if someone experiences memory loss, or a 'blackout,' while drinking alcohol. While common, blackouts are considered a public health concern linked to injury, arrest, assault and overdose.

20 May 2026

Vitamin D deficiency linked to higher postoperative breast cancer pain

Vitamin D deficiency is associated with more moderate to severe pain following breast cancer surgery and an increased consumption of opioid drugs, finds research published online in the journal Regional Anesthesia & Pain Medicine.

19 May 2026

WHO warns of rising nicotine pouch addiction among youth

The World Health Organization (WHO) today issues a strong warning over the rapid global expansion of nicotine pouch products, which are being aggressively marketed to adolescents and young people.

17 May 2026

Retinal stimulation via contact lenses effective as antidepressants in mice

Materials scientists have designed brain-stimulating contact lenses that are as effective as Prozac at treating depression in mice. The soft, transparent contact lenses have in-built electrodes that deliver mild electrical signals to the brain via the retina to stimulate specific brain regions associated with depression.

14 May 2026

New research maps the biological toll of drinking

A new review published in the journal Addiction confirms drinking causes substantial harm to health. Some of those harms may be reversible if the person reduces or stops drinking.

14 May 2026

Targeted ultrasound stimulation alters brain processing to reduce chronic pain

Using ultrasound to stimulate a specific part of the brain could offer a non-invasive therapy that benefits those experiencing chronic pain, a new study has suggested.

13 May 2026

FoMO and anxiety may increase addictive eating risk

Research shows FoMO influences addictive eating, with anxiety heightening reward-driven cravings for ultra-processed foods and compulsive overeating.

12 May 2026

New obesity drugs may shift blame toward food industry

An essay presented at this year's European Congress on Obesity in Istanbul, Turkey (12-15 May) suggests that new age of obesity drugs could shift the blame for living with obesity from individuals to the food industry – just as smoking has been blamed on tobacco industry and to a lesser extent alcohol consumption on the alcohol industry.

11 May 2026

A brain-based approach may improve smoking cessation treatment success

For many people who smoke, quitting is not just a matter of willpower. It is a tug-of-war in the brain – between the pull of reward and the ability to resist.

8 May 2026

Opioid overdose survivors face elevated mortality risk within one year

After an emergency department visit for an opioid overdose, 9 per cent of individuals died and 21 per cent experienced a repeat opioid overdose in the following year, according to a new study from ICES and the Centre for Addiction and Mental Health (CAMH).

7 May 2026

GLP-1 drugs may reshape how brain values rewarding foods

A new study from the University of Virginia reveals that a widely used class of weight-loss drugs does more than suppress appetite-it directly alters brain circuits that control motivation and reward.

6 May 2026

Single psilocybin dose linked to lasting brain and mood changes

Researchers at UC San Francisco and Imperial College London have shown that a single dose of psilocybin, the psychedelic compound found in magic mushrooms, causes likely anatomical brain changes that last for up to a month after the experience.

5 May 2026